Malaysia: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)   |   MY2022-0014

Malaysia’s Biosafety Act 2007 and Biosecurity Regulations are currently under review by the Department of Biosafety. As of September 2022, 57 genetically engineered (GE) products have been approved for import, an increase of 14 percent from 2021. Malaysia does not currently have any domestic production of plant biotechnology. However, the country continues to expand the number of approved GE products for commercial use. The Malaysian Ministry of Health established mandatory GE labeling guidelines in 2013, but, they have yet to be enforced. On September 12, 2022, Malaysia launched the National Biotechnology Policy 2.0 which focuses on agriculture, food security, healthcare, and wellbeing with no mention of Genetic Modification (GM) or GE policies or initiatives.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.